Search

everythinglearnresearchcommunity

for

Search:↓

Both finasteride and GnRH agonist treatments reduced hair growth in women with idiopathic hirsutism, but GnRH agonist was more effective.

Hydralazine and minoxidil are blood pressure medications that relax blood vessels, with potential side effects like rapid heartbeat and fluid retention, and are used for severe or pregnancy-related hypertension.

Dutasteride is more effective than finasteride for hair growth, and sublingual apomorphine quickly improves Parkinson's symptoms.

Certain medications can cause serious side effects, so it's important to report them.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

Progesterone reduces anxiety and depression in female mice by increasing BDNF in the brain, needing 5α-reduction and estradiol.

Delta opioid receptors help regulate touch sensation by reducing neurotransmitter release in the spinal cord.

New treatments for alcohol, opioid, and cannabis addiction include medications, therapy, and personalized plans.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

Trazodone and chlorpromazine may help treat sexual dysfunction caused by finasteride and SSRIs.

TRPA1 and TRPV1 channels don't affect mechanotransduction in rat sinus hair follicles.

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

2-DG reduces seizures by enhancing brain inhibition through specific receptor activation.

Bimatoprost treats glaucoma and promotes hair growth, with potential for more medical uses.

A compound named ZCZ90 can increase muscle spindle firing, potentially helping treat muscle spasms and hypertension.

GnRH agonists can help manage recurrent priapism in sickle cell patients, but long-term safety is unclear.

Dienogest is safer and has fewer side effects than GnRH analogues for treating endometriosis.

Oral difelikefalin significantly reduces itch in notalgia paresthetica.

Provenge extends prostate cancer survival by about 4 months.

The document concludes that biotin, folate, and RGD peptides are promising for targeting cancer cells with prodrugs, but the conjugates are not yet tested for use.

Blocking 5α-reductase can reduce sleep deprivation-related behavioral issues in rats.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

Minoxidil and ranolazine together can reduce the spread of certain breast cancer cells.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Allopregnanolone increases growth and changes gene activity in human brain cancer cells.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Removing certain brain receptors in mice worsens seizure severity and response to treatment during hormone withdrawal.

Thyroid receptor β can help develop new drugs to treat hair loss.